Sign Up to like & get
recommendations!
2
Published in 2022 at "Scientific Reports"
DOI: 10.1038/s41598-022-10139-6
Abstract: [177Lu]Lu-DOTA-NNV003, a radioimmunoconjugate targeting CD37, is developed as novel radioimmunotherapy (RIT) treatment for patients with B cell non-Hodgkin’s lymphoma (NHL). Since patients are at risk for developing hematological toxicities due to CD37 expression on normal…
read more here.
Keywords:
tumor uptake;
89zr sucdf;
tumor;
pet imaging ... See more keywords